Somatostatin receptors on peripheral primary afferent terminals: Inhibition of sensitized nociceptors

Keyphrases

• Primary Afferent 100%
• Nociceptor 100%
• Octreotide 100%
• Somatostatin Receptor 100%
• Analgesia 40%
• Formalin 40%
• Bradykinin 40%
• Central Nervous System Effects 40%
• Behavioral Effects 20%
• Receptor Antagonist 20%
• Neurotoxicity 20%
• Inflammation 20%
• Primary Afferent Fibers 20%
• Experimental Animals 20%
• Dose Effect 20%
• Central Nervous System 20%
• Somatostatin 20%
• Nociception 20%
• Primary Afferent Neuron 20%
• Inflammatory Pain 20%
• Pain Treatment 20%
• Somatostatin Agonists 20%
• Nociceptive Behavior 20%
• Glabrous Skin 20%
• Thermal Stimulation 20%
• Intrathecal Administration 20%
• Sensory Fibers 20%
• Cyclosomatostatin 20%
• Co-injection 20%
• Physiological Effects 20%
• Somatostatin Receptor Agonists 20%
• SSTR2A 20%
• Epidural Administration 20%

Medicine and Dentistry

• Nociceptor 100%
• Octreotide 100%
• Somatostatin Receptor 100%
• Central Nervous System 60%
• Somatostatin 60%
• Sensitization 40%
• Analgesia 40%
• Bradykinin 40%
• Side Effect 40%
• Receptor Antagonist 20%
• Inflammatory Pain 20%
• Nociception 20%
• Treatment of Pain 20%
• Neurotoxicity 20%
• Intrathecal Drug Administration 20%
• Afferent Neuron 20%
• Glabrous Skin 20%
• Intraplantar Drug Administration 20%
• Epidural Drug Administration 20%
• Thermal Stimulation 20%
• Somatostatin Receptor Agonist 20%

Neuroscience

• Nociceptor 100%
• Octreotide 100%
• Somatostatin Receptor 100%
• Central Nervous System 60%
• Somatostatin 60%
• Bradykinin 40%
• Side Effect 40%
• Receptor Antagonist 20%
• Neurotoxicity 20%
• Behavior (Neuroscience) 20%
• Intrathecal 20%
• Nociception 20%
• Agonist 20%
• Receptor Agonists 20%
• Afferent Neurons 20%
• Treatment of Pain 20%